https://med.stanford.edu/news/all-news/2025/08/blood-cancer-drug.html
Stanford Medicine-led trial leads to FDA approval of drug for rare, deadly blood cancer
Fewer than half of people diagnosed with a subtype of myeloid/lymphoid neoplasms are alive one year later. A multicenter Phase 2 trial led by Stanford Medicine...
stanford medicine ledtrialfda
https://www.9news.com.au/health/myeloma-blood-cancer-pbs-australia-health/5c4f3e3a-0296-441a-aeb6-a223086f93eb
Australia health news: Treatment for deadly blood cancer multiple myeloma to be significantly...
Nov 13, 2025 - The cost of a crucial treatment for a deadly cancer will drop from nearly $13,000 a month to just $25 a mon...
deadly blood canceraustralia